Females with angina pectoris have altered lipoprotein metabolism with elevated cholesteryl ester transfer protein activity and impaired high-density lipoproteins-associated antioxidant enzymes

1Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

In order to investigate non-invasive biomarkers for angina pectoris (AP), we analyzed the lipid and protein composition in individual lipoproteins from females with angina pectoris (n=22) and age- and gender-matched controls (n=20). In the low-density lipoprotein (LDL) fraction, the triglycerides (TG) and protein content increased in the AP group compared to the control group. The AP group had lower total cholesterol (TC) and elevated TG in the high-density lipoprotein (HDL) fraction. In the AP group, cholesteryl ester transfer protein (CETP) activity was enhanced in HDL and LDL, while lecithin:cholesterol acyltransferase (LCAT) activity in HDL 3 was almost depleted. Antioxidant activity was significantly decreased in the HDL 3 fraction, with a decrease in the HDL 2 particle size. In the HDL 3 fraction, paraoxonase and platelet activating factor- acetylhydrolase (PAF-AH) activity were much lower and the levels of CETP and apoC-III were elevated in the AP group. The LDL from the AP group was more sensitive to cupric ion-mediated oxidation with faster mobility. In conclusion, the lipoprotein fractions in the AP group had impaired antioxidant activity and increased TG and apoC-III with structural and functional changes.

Figures

  • Table I. Lipid and protein composition of lipoproteins from patients.
  • Figure 1. Immunodetection of apolipoproteins and enzymes in HDL3 between the angina pectoris (AP) and control groups. Equal amounts of HDL3 (6 µg of protein) from an individual subject were loaded per lane. Polyclonal CETP antibody (Abcam, ab19012), apoC-III antibody (Chemicon, AB821), and LCAT antibody (Abcam, ab786) were used as primary antibodies.
  • Figure 2. Comparison of the antioxidant activity of HDL. Reduction potential of HDL3 based on the ferric-reducing ability of plasma (FRAP). The same amount of HDL3 (0.05 ml, 2 mg/ml) was added to the substrate solution. Comparison of electrophoretic mobility of HDL2 on 0.7% agarose gels without cupric ion treatment.
  • Figure 3. Properties of HDL2 from the AP and control groups. Susceptibility to oxidation in HDL2 by cupric ion treatment (graph). Representative picture of negatively-stained HDL2 from the angina pectoris (AP) and control groups (electron microscopy, bottom photo). All micrographs are shown at
  • Table II. LCAT and CETP activities in lipoprotein fractions.
  • Figure 4. Activities of HDL-associated antioxidant enzymes, (A) paraoxonase and (B) platelet activating factor-acetylhydrolase (PAF-AH), between the angina pectoris (AP) and control groups. An equal amount of individual HDL2 and HDL3 were used as each enzyme source.
  • Figure 5. Oxidized extent of LDL with or without cupric ion treatment between the angina pectoris (AP) and control groups. *P<0.05 and #P<0.01 vs. the control.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Park, J., Kim, J. R., Shin, D. G., & Cho, K. H. (2012). Females with angina pectoris have altered lipoprotein metabolism with elevated cholesteryl ester transfer protein activity and impaired high-density lipoproteins-associated antioxidant enzymes. International Journal of Molecular Medicine, 29(4), 683–689. https://doi.org/10.3892/ijmm.2011.874

Readers over time

‘13‘16‘18‘20‘2200.751.52.253

Readers' Seniority

Tooltip

Researcher 2

67%

PhD / Post grad / Masters / Doc 1

33%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

67%

Agricultural and Biological Sciences 1

33%

Save time finding and organizing research with Mendeley

Sign up for free
0